This feature article is written by Zoya Vassilieva, a director at PricewaterhouseCoopers Thailand. It looks at trends and development paths of domestic Asian pharmaceutical companies, and potential M&A opportunities for MNCs in Asia.


-----------------------------------------------------------------------------------------

This is not an article published by Pharma China, and please visit the following website link for the full text of the article.  The availability of the article is under the control of its publisher. 

http://www.bangkokpost.com/Business/21Aug2007_biz31.php

Note: By clicking on the above link, you will leave Pharma China Online. If you wish to return to this website, please click on "Back" button or log onto Pharma China Online again.